Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for cognition in children with partial-onset seizures
NCT01527513Phase 2Completed
- Sponsor
- BIAL
- Start
- Aug 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of eslicarbazepine acetate in partial epilepsy, sponsored by BIAL. Started Aug 2010; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT01527513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527513.